Bimekizumab's safety profile was evaluated using FAERS data, identifying 2780 reports and 70 significant safety signals. The study found 29 previously unreported adverse events, including cellulitis ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence (Nasdaq: CDNS) today announced it has entered into a definitive agreement to acquire the Design & Engineering (“D&E”) business of Hexagon AB, which includes ...
This year, TIME has published its first ranking of the World's Top HealthTech Companies, in partnership with Statista, a leading international provider of market and consumer data and rankings. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results